Pharmaceutical

SK bioscience’s typhoid vaccine receives WHO prequalification

SK bioscience has achieved a significant milestone with its typhoid conjugate vaccine, SKYTyphoid, receiving WHO prequalification.

Feb 26, 2024 - 18:00
SK bioscience’s typhoid vaccine receives WHO prequalification
SK bioscience has achieved a significant milestone with its typhoid conjugate vaccine, SKYTyphoid, receiving WHO prequalification.
Read the original article

Tags:

Previous Article

Merck’s Keytruda regimen gains positive EMA CHMP opinion

Next Article

Moderna concludes construction at new mRNA vaccine facility in Canada

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Opinion: Insurance companies are forcing psychiatrists like me to stop accepting their coverage

Opinion: Insurance companies are forcing psychiatrists ...

Jan 4, 2024

Opinion: How kangaroo mother care can help millions of babies each year

Opinion: How kangaroo mother care can help millions of ...

Oct 12, 2023

STAT+: Biogen board and C-suite are in step as they eye M&A opportunities, new CEO says

STAT+: Biogen board and C-suite are in step as they eye...

Jun 6, 2023